Allergic rhinitis is a common and chronic immunoglobulin E–mediated respiratory illness that can affect quality of life and productivity, as well as exacerbate other conditions such as asthma.
Treatment should be based on the patient's age and severity of symptoms.
These include trimethoprim-sulfamethoxazole, tetracycline, clindamycin, fluoroquinolones, and linezolid.
Retapamulin is a topical antibiotic available as a 1% ointment.
Subcutaneous or sublingual immunotherapy should be considered if usual treatments do not adequately control symptoms and in patients with allergic asthma.
Patients should be educated about their condition and advised to avoid known allergens.
Intranasal corticosteroids are the most effective treatment and should be first-line therapy for persistent symptoms affecting quality of life.
Antihistamines may be prescribed for symptomatic relief in patients with pruritus.
Mupirocin applied topically has been shown to be effective for localized impetigo, but resistance has emerged. Systemic antibiotic treatment is indicated for widespread infections, complicated infections, or those associated with systemic manifestations.